NCT05258838

Brief Summary

National cross-sectional multicentric study to describe the epidemiological characteristics of patients with Psoriasis in Tunisia

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,100

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 28, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

July 12, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 17, 2025

Status Verified

February 1, 2025

Enrollment Period

2.5 years

First QC Date

February 14, 2022

Last Update Submit

February 13, 2025

Conditions

Psoriasis

Keywords

PsoriasisDermatologyTunisiaDacima

Outcome Measures

Primary Outcomes (1)

  • Psoriasis types

    Number of subjects with each type of psoriasis (Plaque psoriasis, Inverse psoriasis, Erythrodermic, Guttate psoriasis, Nail psoriasis, Pustular psoriasis, Psoriatic arthritis)

    At inclusion

Secondary Outcomes (2)

  • Demographic

    At inclusion

  • Safety assessment of psoriasis medical treatment

    At inclusion

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized or outpatient subjects with psoriasis

You may qualify if:

  • Patients with psoriasis
  • Informed and written consent

You may not qualify if:

  • Any dermatology disease other than psoriasis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Société Tunisienne de Dermatologie et de Vénéréologie

Tunis, Tunisia, Tunisia

Location

Related Links

MeSH Terms

Conditions

Psoriasis

Condition Hierarchy (Ancestors)

Skin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Houda Hammami, MD

    University Hospital of Habib Thameur, Ben Arous, Tunisia

    STUDY CHAIR

  • Mohamed Denguezli, MD

    University Hospital of Farhat Hached, Sousse, Tunisia

    STUDY CHAIR

  • Asmahen Souissi, MD

    dr.asmahanesouissi@gmail.com

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2022

First Posted

February 28, 2022

Study Start

July 12, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

February 17, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)